angiotensin ii has been researched along with nitroblue tetrazolium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Le Morvan, P; Palaic, D | 1 |
Ferrario, CM; Gallagher, PE; Ganten, D; Strawn, WB; Tallant, EA | 1 |
Chen, Y; Luo, Z; Pearlman, A; Wilcox, CS | 1 |
3 other study(ies) available for angiotensin ii and nitroblue tetrazolium
Article | Year |
---|---|
Characterization of the angiotensin receptor in guinea-pig aorta.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Membrane; Glucose-6-Phosphatase; Guinea Pigs; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Male; Mitochondria; Nitroblue Tetrazolium; Nucleotidases; Protein Binding; Receptors, Drug; Succinate Dehydrogenase | 1975 |
Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Cell Count; Blood Pressure; Cell Adhesion; Endothelium, Vascular; Female; Heart Rate; Hematocrit; Hydralazine; Hypertension; Losartan; Male; Monocytes; Nitroblue Tetrazolium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Antioxidants; Catalase; Cells, Cultured; Cyclic N-Oxides; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroblue Tetrazolium; Norepinephrine; Oxidative Stress; Potassium Channels; Rats; Rats, Inbred SHR; Spin Labels; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |